Novel transcript antisense to HOXC12

The "novel transcript antisense to HOXC12" (ENSG00000293679) is a noncoding RNA transcribed from the DNA region opposite to the HOXC12 gene. Antisense RNAs can regulate the expression of their sense counterparts by mechanisms including transcriptional interference, chromatin modification, and transcript stability[3][5]. Although antisense transcription is common in eukaryotes and has been shown to influence chromatin and gene expression, the functional and pathological relevance of this particular antisense to HOXC12 remains unknown. No data currently support the designation of this transcript as a conventional therapeutic target, clinical biomarker, or drug-interacting entity. Existing research on HOXC12 (the protein-coding gene) points toward a role in cancer invasion, migration, and signaling[1][2][4], but the antisense transcript itself has not been functionally characterized. Note: - The abbreviation "ENSG00000293679" refers to its Ensembl gene ID and is not a canonical abbreviation for a drug target. - This transcript does not meet the definition of a typical therapeutic target (receptor, enzyme, transporter). There is no indication in the literature that it is actively targeted by drugs or utilized as a clinical biomarker. - This entry is likely an annotation artifact or an uncharacterized transcript, necessitating further research to elucidate any potential biological or therapeutic relevance.

Other names

ENSG00000293679